Communiqués Blue Water Ventures International, Inc.

Actions

BWVI

US09609E1055

Marché Fermé - OTC Markets Autres places de cotation 19:56:45 27/06/2024			Varia. 5j.	Varia. 1 janv.
0,0013 ^USD	0,00 %		+8,33 %	-97,90 %

2023	Psycheceutical Bioscience, Inc. annonce des changements au sein de son conseil d'administration	CI
2023	Psycheceutical Bioscience, Inc. nomme Neilank K. Jha comme nouveau président exécutif	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Veru Sells ENTADFI Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones	21/04/23	AQ
Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review	13/04/23	PR
Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab	29/03/23	GL
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD	21/03/23	GL
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD	21/03/23	AQ
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD	15/02/23	GL
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD	15/02/23	AQ
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD	02/02/23	GL
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD	02/02/23	AQ
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD	26/01/23	GL
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD	26/01/23	AQ
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer	10/01/23	GL
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer	10/01/23	AQ
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director	29/11/22	GL
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director	29/11/22	AQ
Mannatech is Reinventing Hydration Introduces Exclusive Blue Water	07/11/22	AQ
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board	18/10/22	GL
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board	18/10/22	AQ
Kevin Harrington, Original Shark from Shark Tank and Futurist Zappy Zapolin to Open Wonderland 2022	05/10/22	NE
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council	04/10/22	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Blue Water Ventures International, Inc.

Actions

BWVI

US09609E1055

Communiqués

Filtres